From the labto the hospital

Gastrointestinal and Endocrine Tumours

Grup de tumors gastrointestinals i endocrins a Vall d'Hebron

The Gastrointestinal and Endocrine Tumours group centres its strategies around discovering new biomarkers in gastrointestinal tumour formation, validating new biomarkers and identifying predictive markers. It does so by developing strategies to identify patient populations and new drugs targeted at different cancer properties.


The group aims to discover and validate new biomarkers, as well as develop clinical models that are relevant in vitro and in vivo, emphasising the identification of predictive markers, with the ultimate goal of improving the diagnosis and prognosis of these types of cancer.

The group takes part in international multidisciplinary consortia and collaborative research programmes. It also works with academic groups and pharmaceutical companies on the validation of repositioning drugs or candidate drugs, while extending collaboration with other VHIO teams.

Visit the research group’s page